David Latshaw BioPhy

Dave is a globally recognized expert in artificial intelligence (AI) who serves as Chief Executive Officer and Chief Scientific Officer of BioPhy. Dave’s deep expertise at the intersection of AI and Biotechnology led to the creation, development and launch of the innovative BioPhy technology platform. Along with leading the company, Dave actively directs all scientific research and technology development, as well as overseeing day-to-day operations.
Prior to co-founding BioPhy, Dave was a Sr. Scientist at Janssen (Johnson and Johnson) and a lead in the Advanced Technologies Center of Excellence, where he designed and implemented global scale AI technology across multiple areas of the drug development lifecycle.
Notably, Dave’s work has been recognized and profiled by the World Economic Forum and McKinsey & Company. Dave has also been selected as a member of the Frontiers of Engineering, a part of the National Academy of Engineering, and a member of PA Governor’s Life Sciences Task Force. Dave and BioPhy have featured in Forbes, Axios, Venture Beat, Fierce Healthcare, Endpoints, Politico and other publications.